• 1
    Mahley RW, Weisgraber KH. Canine lipoproteins and atherosclerosis: I. isolation and characterization of plasma lipoproteins from control dogs. Circ Res. 1974;35:713721.
  • 2
    Burchardt P, Zurawski J, Zuchowski B, et al. Low-density lipoprotein, its susceptibility to oxidation and the role of lipoprotein-associated phospholipase A2 and carboxyl ester lipase lipases in atherosclerotic plaque formation. Arch Med Sci. 2013;9:151158.
  • 3
    Mineo C, Shaul PW. Novel biological functions of high-density lipoprotein cholesterol. Circ Res. 2012;111:10791790.
  • 4
    Zhu X, Parks JS. New roles of HDL in inflammation and hematopoiesis. Annu Rev Nutr. 2012;32:161182.
  • 5
    Suda  , Akamatsu A, Nakaya Y, Masuda Y, Desaki J. Alterations in erythrocyte membrane lipid and its fragility in a patient with familial lecithin:cholesterol acyltrasferase (LCAT) deficiency. J Med Invest. 2002;49:147155.
  • 6
    Allen DW, Manning N. Cholesterol-loading of membranes of normal erythrocytes inhibits phospholipid repair and arachidonoyl-CoA:1-palmitoyl-sn-glycero-3-phosphocholine acyl transferase. A model of spur cell anemia. Blood. 1996;87:34893493.
  • 7
    London IM, Schwarz H. Erythrocyte metabolism; the metabolic behavior of the cholesterol human erythrocytes. J Clin Invest. 1953;32:12481252.
  • 8
    Akahane K, Furuhama K, Onodera T. Simultaneous occurrence of hypercholesterolemia and hemolytic anemia in rats fed cholesterol diet. Life Sci. 1986;39:499505.
  • 9
    Sengupta A, Ghosh M. Integrity of erythrocytes of hypercholesterolemic and normocholesterolemic rats during ingestion of different structured lipids. Eur J Nutr. 2011;50:411419.
  • 10
    Cooper RA, Leslie MH, Knight D, Detweiler DK. Red cell cholesterol enrichment and spur cell anemia in dogs fed a cholesterol-enriched atherogenic diet. J Lipid Res. 1980;21:10821089.
  • 11
    Abdelhalim MA, Moussa SA. Biochemical changes of hemoglobin and osmotic fragility of red blood cells in high fat diet rabbits. Pak J Biol Sci. 2010;13:7377.
  • 12
    Wen ZY, Song LC, Yan ZY, et al. An animal model to study erythrocyte senescence with a narrow time window of erythrocyte production: alterations in osmotic fragility and deformability of erythrocytes during their life span. Am J Hematol. 2013;88:4451.
  • 13
    Paltrinieri S, Comazzi S, Agnes F. Haematological parameters and altered erythrocyte metabolism in anaemic dogs. J Comp Pathol. 2000;122:2534.
  • 14
    Parpart AK, Lorenz PB. The osmotic resistance (fragility) of human red cells. J Clin Invest. 1947;26:636640.
  • 15
    Maturu P, Vaddi DR, Pannuru P, Nallanchakravarthula V. Alterations in erythrocyte membrane fluidity and Na+/K+ -ATPase activity in chronic alcoholics. Mol Cell Biochem. 2010;339:3542.
  • 16
    Bosomworth NJ. Approach to identifying and managing atherogenic dyslipidemia: a metabolic consequence of obesity and diabetes. Can Fam Physician. 2013;59:11691180.
  • 17
    Chanson P, Salenave S. Metabolic syndrome in Cushing's syndrome. Neuroendocrinology. 2010;92(Suppl 1):96101.
  • 18
    Meurs I, Hoekstra M, van Wanrooij EJ, et al. HDL cholesterol levels are an important factor for determining the lifespan of erythrocytes. Exp Hematol. 2005;33:13091319.
  • 19
    Holm TM, Braun A, Trigatti BL, et al. Failure of red blood cell maturation in mice with defects in the high-density lipoprotein receptor SR-BI. Blood. 2002;99:18171824.
  • 20
    Uydu HA, Yıldırmış S, Orem C, et al. The effects of atorvastatin therapy on rheological characteristics of erythrocyte membrane, serum lipid profile and oxidative status in patients with dyslipidemia. J Membr Biol. 2012;245:697705.
  • 21
    Broncel M, Bała A, Koter-Michalak M, Duchnowicz P, Wojsznis W, Chojnowska-Jezierska J. Physicochemical modifications induced by statins therapy on human erythrocytes membranes. Wiad Lek. 2007;60:321328.
  • 22
    Jóźwiak Z, Pałecz D, Bartosz G. The interactions of modified lipoproteins with human erythrocyte membranes. Biochem Mol Biol Int. 1994;32:259267.
  • 23
    Wang X, Yang L, Liu Y, et al. Oxidized low-density lipoprotein (Ox-LDL) impacts on erythrocyte viscoelasticity and its molecular mechanism. J Biomech. 2009;42:23942399.
  • 24
    Poulet FM, Penraat K, Collins N, et al. Drug-induced hemolytic anemia and thrombocytopenia associated with alterations of cell membrane lipids and acanthocyte formation. Toxicol Pathol. 2010;38:907922.
  • 25
    Comazzi S, Paltrinieri S, Spagnolo V, Sartorelli P. Some aspects of erythrocyte metabolism in insulin-treated diabetic dogs. Res Vet Sci. 2002;72:2327.
  • 26
    Lippi G, Mercadanti M, Aloe R, Targher G. Erythrocyte mechanical fragility is increased in patients with type 2 diabetes. Eur J Intern Med. 2012;23:150153.
  • 27
    Jain SK. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. J Biol Chem. 1989;264:2134021345.
  • 28
    Kung CM, Tseng ZL, Wang HL. Erythrocyte fragility increases with level of glycosylated hemoglobin in type 2 diabetic patients. Clin Hemorheol Microcirc. 2009;43:345351.
  • 29
    Cooper RA, Jandl JH. The role of membrane lipids in the survival of red cells in hereditary spherocytosis. J Clin Invest. 1969;48:736744.
  • 30
    Hu W, Jin R, Zhang J, et al. The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis model. Blood. 2010;116:16131622.
  • 31
    Frimat M, Tabarin F, Dimitrov JD, et al. Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome. Blood. 2013;122:282292.